| Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease L Miele, V Valenza, G La Torre, M Montalto, G Cammarota, R Ricci, ... Hepatology 49 (6), 1877-1887, 2009 | 1705 | 2009 |
| Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups A Lonardo, S Bellentani, CK Argo, S Ballestri, CD Byrne, SH Caldwell, ... Digestive and Liver Disease 47 (12), 997-1006, 2015 | 519 | 2015 |
| The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota ML Balmer, E Slack, A De Gottardi, MAE Lawson, S Hapfelmeier, L Miele, ... Science translational medicine 6 (237), 237ra66-237ra66, 2014 | 465 | 2014 |
| Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease: A decalogue from the Italian Association for the Study of the Liver (AISF) Expert … P Loria, LE Adinolfi, S Bellentani, E Bugianesi, A Grieco, S Fargion, ... Digestive and Liver Disease 42 (4), 272-282, 2010 | 353 | 2010 |
| Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging … A Grieco, M Pompili, G Caminiti, L Miele, M Covino, B Alfei, GL Rapaccini, ... Gut 54 (3), 411-418, 2005 | 342 | 2005 |
| Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial C Loguercio, P Andreone, C Brisc, MC Brisc, E Bugianesi, M Chiaramonte, ... Free Radical Biology and Medicine 52 (9), 1658-1665, 2012 | 322 | 2012 |
| AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions A Lonardo, F Nascimbeni, G Targher, M Bernardi, F Bonino, E Bugianesi, ... Digestive and Liver Disease 49 (5), 471-483, 2017 | 309 | 2017 |
| Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis L Miele, S Vallone, C Cefalo, G La Torre, C Di Stasi, FM Vecchio, ... Journal of hepatology 51 (4), 778-786, 2009 | 290 | 2009 |
| NAFLD in children: new genes, new diagnostic modalities and new drugs V Nobili, A Alisi, L Valenti, L Miele, AE Feldstein, N Alkhouri Nature reviews Gastroenterology & hepatology 16 (9), 517-530, 2019 | 267 | 2019 |
| MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals B Donati, P Dongiovanni, S Romeo, M Meroni, M McCain, L Miele, S Petta, ... Scientific reports 7 (1), 4492, 2017 | 257 | 2017 |
| Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores C Bianco, O Jamialahmadi, S Pelusi, G Baselli, P Dongiovanni, I Zanoni, ... Journal of hepatology 74 (4), 775-782, 2021 | 248 | 2021 |
| NASH in lean individuals R Younes, E Bugianesi Seminars in liver disease 39 (01), 086-095, 2019 | 241 | 2019 |
| The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease L Miele, G Beale, G Patman, V Nobili, J Leathart, A Grieco, M Abate, ... Gastroenterology 135 (1), 282-291. e1, 2008 | 224 | 2008 |
| Pathophysiology of non alcoholic fatty liver disease S Petta, A Gastaldelli, E Rebelos, E Bugianesi, P Messa, L Miele, ... International journal of molecular sciences 17 (12), 2082, 2016 | 223 | 2016 |
| Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis EA Selvaraj, FE Mózes, ANA Jayaswal, MH Zafarmand, Y Vali, JA Lee, ... Journal of hepatology 75 (4), 770-785, 2021 | 218 | 2021 |
| A 360-degree overview of paediatric NAFLD: recent insights V Nobili, G Svegliati-Baroni, A Alisi, L Miele, L Valenti, P Vajro Journal of hepatology 58 (6), 1218-1229, 2013 | 204 | 2013 |
| Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity V Giorgio, L Miele, L Principessa, F Ferretti, MP Villa, V Negro, A Grieco, ... Digestive and Liver Disease 46 (6), 556-560, 2014 | 194 | 2014 |
| Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome G Targher, M Chonchol, L Miele, G Zoppini, I Pichiri, M Muggeo Seminars in thrombosis and hemostasis 35 (03), 277-287, 2009 | 186 | 2009 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 180 | 2022 |
| Impact of gut microbiota on obesity, diabetes, and cardiovascular disease risk L Miele, V Giorgio, MA Alberelli, E De Candia, A Gasbarrini, A Grieco Current cardiology reports 17, 1-7, 2015 | 177 | 2015 |
Antonio GriecoProfessore associato, Università cattolica del sacro cuore, Facoltà di Medicina e Chirurgia A. Gemelli, Roma在 rm.unicatt.it 的电子邮件经过验证
